ESCITALOPRAM Drug Patent Profile
✉ Email this page to a colleague
When do Escitalopram patents expire, and when can generic versions of Escitalopram launch?
Escitalopram is a drug marketed by Norvium Bioscience, Amneal Pharms, Antrim Pharms Llc, Aurobindo Pharma Ltd, Chartwell Molecular, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Taro, Accord Hlthcare, Anima, Chartwell Rx, Dash Pharms, Graviti Pharms, Hikma Pharms, Invagen Pharms, Jubilant Cadista, Prinston Inc, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Lifesciences. and is included in twenty-three NDAs.
The generic ingredient in ESCITALOPRAM is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Escitalopram
A generic version of ESCITALOPRAM was approved as escitalopram oxalate by AMNEAL PHARMS on March 14th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ESCITALOPRAM?
- What are the global sales for ESCITALOPRAM?
- What is Average Wholesale Price for ESCITALOPRAM?
Summary for ESCITALOPRAM
| US Patents: | 0 |
| Applicants: | 20 |
| NDAs: | 23 |
| Drug Prices: | Drug price information for ESCITALOPRAM |
| Drug Sales Revenues: | Drug sales revenues for ESCITALOPRAM |
| DailyMed Link: | ESCITALOPRAM at DailyMed |
See drug prices for ESCITALOPRAM
US Patents and Regulatory Information for ESCITALOPRAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Macleods Pharms Ltd | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 202210-001 | Sep 11, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma Pharms | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 078766-001 | Sep 11, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms Usa | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 076765-003 | Mar 14, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Prinston Inc | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 078032-002 | Aug 28, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Torrent Pharms Ltd | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 090939-001 | Sep 11, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Lifesciences | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 077734-003 | Sep 11, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
